Recent progress in the study on antitumor drugs targeting hypoxia-inducible factor-1 / 药学学报
Acta Pharmaceutica Sinica
;
(12): 565-569, 2008.
Artículo
en Chino
| WPRIM
| ID: wpr-277795
ABSTRACT
Hypoxia-inducible factor-1 (HIF-1), as a transcription factor, plays an important role in the adaptation to hypoxic microenvironment within tumors. It can induce a series of genes transcription that participate in angiogenesis, glucose metabolism, cell proliferation, and cell migration/invasion. Thus HIF-1 not only allows cancer cells to survive in hypoxic microenvironment, but also makes the tumor more aggressive. Moreover, HIF-1 also induces tumors to acquire resistance to chemo-/radio-therapy, and is related to poor prognosis. HIF-1 emerges gradually as a potential target to develop new antitumor drugs. This paper reviews recent progress in this field.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Farmacología
/
Transcripción Genética
/
Anfotericina B
/
Topotecan
/
Sirolimus
/
Equinomicina
/
Factor 1 Inducible por Hipoxia
/
Genética
/
Indazoles
/
Metabolismo
Tipo de estudio:
Estudio pronóstico
Límite:
Animales
/
Humanos
Idioma:
Chino
Revista:
Acta Pharmaceutica Sinica
Año:
2008
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS